Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Wave Life Sciences (WVE) Change in Receivables: 2015-2025

Historic Change in Receivables for Wave Life Sciences (WVE) over the last 4 years, with Sep 2025 value amounting to $8.4 million.

  • Wave Life Sciences' Change in Receivables rose 749.84% to $8.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.0 million, marking a year-over-year increase of 242.86%. This contributed to the annual value of -$19.7 million for FY2024, which is 193.26% down from last year.
  • Wave Life Sciences' Change in Receivables amounted to $8.4 million in Q3 2025, which was up 418.43% from $1.6 million recorded in Q2 2025.
  • In the past 5 years, Wave Life Sciences' Change in Receivables ranged from a high of $14.1 million in Q4 2023 and a low of -$37.5 million during Q3 2021.
  • In the last 3 years, Wave Life Sciences' Change in Receivables had a median value of $1.4 million in 2024 and averaged $1.1 million.
  • In the last 5 years, Wave Life Sciences' Change in Receivables slumped by 118.43% in 2024 and then soared by 749.84% in 2025.
  • Over the past 4 years, Wave Life Sciences' Change in Receivables (Quarterly) stood at -$22.5 million in 2021, then reached $14.1 million in 2023, then plummeted by 89.90% to $1.4 million in 2024, then skyrocketed by 749.84% to $8.4 million in 2025.
  • Its last three reported values are $8.4 million in Q3 2025, $1.6 million for Q2 2025, and -$1.4 million during Q1 2025.